Adam R Bleeker is a Oklahoma City, Oklahoma based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Adam R Bleeker is 39320 for Ophthalmology in Oklahoma. Adam R Bleeker is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Adam R Bleeker speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Male
Practice Address:
608 Stanton L Young Blvd, Oklahoma City, Oklahoma, 73104-5014
Phone:
605-630-9023
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1508446964
NPI Enumeration Date:
10 Apr, 2021
NPI Last Update On:
06 Jun, 2022
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Adam R Bleeker are as mentioned below.
License Number
Specialization
State
Status
39320
Ophthalmology
Oklahoma
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
10425 Nw 25th Ter, Yukon, Oklahoma
Zip:
73099-5297
Phone Number:
605-630-9023
Fax Number:
--
Patients can reach Adam R Bleeker at 608 Stanton L Young Blvd, Oklahoma City, Oklahoma or can call to book an appointment on 605-630-9023. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.